BioAge Labs, Inc. (BIOA)

BioAge Labs Statistics

Total Valuation

BioAge Labs has a market cap or net worth of $160.79 million. The enterprise value is -$141.18 million.

Market Cap	160.79M
Enterprise Value	-141.18M

Important Dates

The last earnings date was Wednesday, August 6, 2025, after market close.

Earnings Date	Aug 6, 2025
Ex-Dividend Date	n/a

Share Statistics

BioAge Labs has 35.85 million shares outstanding. The number of shares has increased by 1,552.56% in one year.

Current Share Class	35.85M
Shares Outstanding	35.85M
Shares Change (YoY)	+1,552.56%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	3.64%
Owned by Institutions (%)	48.26%
Float	23.82M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	32.82
Forward PS	n/a
PB Ratio	0.55
P/TBV Ratio	0.55
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 13.21, with a Debt / Equity ratio of 0.03.

Current Ratio	13.21
Quick Ratio	13.09
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-78.53

Financial Efficiency

Return on equity (ROE) is -35.88% and return on invested capital (ROIC) is -24.77%.

Return on Equity (ROE)	-35.88%
Return on Assets (ROA)	-23.46%
Return on Invested Capital (ROIC)	-24.77%
Return on Capital Employed (ROCE)	-30.51%
Revenue Per Employee	$60,359
Profits Per Employee	-$1.23M
Employee Count	64
Asset Turnover	0.02
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	4.43
200-Day Moving Average	6.94
Relative Strength Index (RSI)	54.74
Average Volume (20 Days)	95,008

Short Selling Information

The latest short interest is 2.39 million, so 6.65% of the outstanding shares have been sold short.

Short Interest	2.39M
Short Previous Month	2.31M
Short % of Shares Out	6.65%
Short % of Float	10.01%
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BioAge Labs had revenue of $3.86 million and -$79.03 million in losses. Loss per share was -$2.84.

Revenue	3.86M
Gross Profit	-7.30M
Operating Income	-91.33M
Pretax Income	-62.16M
Net Income	-79.03M
EBITDA	-91.15M
EBIT	-91.33M
Loss Per Share	-$2.84

Balance Sheet

The company has $297.30 million in cash and $8.75 million in debt, giving a net cash position of $304.66 million or $8.50 per share.

Cash & Cash Equivalents	297.30M
Total Debt	8.75M
Net Cash	304.66M
Net Cash Per Share	$8.50
Equity (Book Value)	294.78M
Book Value Per Share	8.22
Working Capital	278.86M

Cash Flow

In the last 12 months, operating cash flow was -$57.40 million and capital expenditures -$916,000, giving a free cash flow of -$58.32 million.

Operating Cash Flow	-57.40M
Capital Expenditures	-916,000
Free Cash Flow	-58.32M
FCF Per Share	-$1.63

Margins

Gross Margin	-188.92%
Operating Margin	-2,364.20%
Pretax Margin	-2,045.74%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BioAge Labs does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1,552.56%
Shareholder Yield	-1,552.56%
Earnings Yield	-48.34%
FCF Yield	-35.67%

Analyst Forecast

The average price target for BioAge Labs is $5.67, which is 26.42% higher than the current price. The consensus rating is "Hold".

Price Target	$5.67
Price Target Difference	26.42%
Analyst Consensus	Hold
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BioAge Labs has an Altman Z-Score of 5.88 and a Piotroski F-Score of 2.

Altman Z-Score	5.88
Piotroski F-Score	2